ASC-10

N/A

Report date: 2023/08/29 15:18:27
NME

Base Information

Drug NameASC-10
Drug Alias NameASC-10ASC10-A的口服双前药
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionRNA-directed RNA polymerase inhibitors
TargetsRNA-directed RNA polymerase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Syncytial Virus InfectionsMonkeypox +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAscletis Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAscletis Pharma IncAscletis Biological Technology (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Syncytial Virus InfectionsMonkeypox +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A